Clinical Trial Update: Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of ondansetron administered as immediate-release (Zofran) and modified-release (EUR1025) formulations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea

Drugs mentioned

• EUR1025 (ondansetron)
• Zofran (Ondansetron)

Snippet

Sponsor: Forest Laboratories | Conditions: Nausea | Phase 1 | Status: COMPLETED